All medicinal products require an assessment of the impact of the product on the environment before authorisation can be granted. Enviresearch can offer expert regulatory and technical advice and support for new medicinal products for human use coming on to the market.
Our team of environmental fate scientists and ecotoxicologists are perfectly placed to offer advice, act as study monitors, and to perform environmental risk assessments for medicinal products for humans and have experience in assessing a range of product types.
Our services include:
- Regulatory advice
- Phase I (pre-screening) & Phase II (Tier A & B, screening & extended) Environmental Risk Assessments for human medicinal products
- Refinement of market penetration factor (Fpen)
- Study contracting and monitoring